Has the Scrutiny Reached a Fever Pitch? Taking the Temperature of Private Equity in Healthcare
July 15, 2024
ABA Our Curious Amalgam
Axinn managing partner Jeny Maier co-hosted ABA's Our Curious Amalgam podcast in an episode entitled, "Has the Scrutiny Reached a Fever Pitch? Taking the Temperature of Private Equity in Healthcare."
Jeny spoke with antitrust attorney Carla Hine to discuss the role private equity plays in health care transactions and what antitrust enforcers’ recent focus means for such transactions.
Click here to access the episode.
To subscribe to our publications, click here.
Featured Insights
Featured Insights
Seven Axinn Attorneys Named to 2025 Capital Pro Bono Honor Roll
Pro Bono
Antitrust
Axinn Advises Thermo Fisher Scientific on $1.075 Billion Sale of its Microbiology Business to Astorg
Deals & Cases
Antitrust
Axinn Appoints Rachael Philbin as Chief Innovation Officer
News
Teva v. Lilly -- Clarifies Written Description of Method Claims Involving A Genus
Axinn Viewpoints
Intellectual Property
What’s Up? Competition Enforcement Updates From Italy and Portugal
Podcast
Antitrust
ACI 22nd Annual Paragraph IV Conference
Speaking Engagement
Intellectual Property
Informa 35th Annual Advanced EU London Conference
Speaking Engagement
Antitrust
Antitrust Fault Lines: Will Licensing Negotiation Groups Reshape SEP Licensing?
Byline Articles
Antitrust
AHLA Health Care Transactions Program 2026
Sponsorship
Antitrust
Kenina Lee Selected as a Member of Law360’s 2026 Competition Editorial Advisory Board
Awards & Recognitions
Antitrust
